Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

Enzalutamide induces cytotoxicity in desmoplastic small round cell tumor independent of the androgen receptor.

Magrath JW, Goldberg IN, Truong DD, Hartono AB, Sampath SS, Jackson CE, Ghosh A, Cardin DL, Zhang H, Ludwig JA, Lee SB
Commun Biol. 2024 Apr 4;7(1):411. doi: 10.1038/s42003-024-06003-0. (Link opens in a new window) PubMed (Link opens in a new window) Article

Plasmids from Article

ID Plasmid Purpose
220560LT3GEPIR-WT1shRNATo inducibly knockdown WT1 or EWSR1::WT1 expression
220561LT3GEPIR-ARshRNA1To inducibly knockdown AR expression
220562LT3GEPIR-ARshRNA2To inducibly knockdown AR expression
220563LT3GEPIR-ARshRNA3To inducibly knockdown AR expression
220564LT3GEPIR-ARshRNA4To inducibly knockdown AR expression
220565pCDH-EWSR1::WT1(-KTS)Lentiviral expression of human EWSR1::WT1(-KTS)
220566pCDH-EWSR1::WT1(+KTS)Lentiviral expression of human EWSR1::WT1(+KTS)

Antibodies from Article